Related by context. All words. (Click for frequent words.) 73 idarubicin 71 standard chemotherapy regimens 71 vinorelbine 71 chemotherapy regimens 70 metastatic RCC 70 carboplatin paclitaxel 70 DMARD therapy 70 chemoradiotherapy 69 chemotherapeutic regimens 69 mycophenolate mofetil 69 cisplatin chemotherapy 69 chemotherapeutic agents 69 dacarbazine 68 5FU 68 relapsed ovarian cancer 68 DMARD 68 temsirolimus 68 adjuvant therapy 68 dose cytarabine 68 cytotoxic agents 68 DOXIL 68 hematologic toxicity 68 lenalidomide dexamethasone 68 anthracyclines 68 metastatic renal cell carcinoma 67 Mitoxantrone 67 overlapping toxicities 67 taxane chemotherapy 67 TACE 67 NRTIs 67 gemcitabine Gemzar 67 external beam radiotherapy 67 relapsed SCLC 67 corticosteroid therapy 67 DMARDs 67 chemoradiation 67 heavily pretreated patients 67 immunosuppressive agents 67 neoadjuvant chemotherapy 67 etoposide 67 Fludara 67 cytotoxic therapy 67 anthracycline 67 EGFR inhibitors 67 mitomycin 67 bevacizumab Avastin ® 67 locoregional 67 daunorubicin 67 TKI therapy 67 calcineurin inhibitors 66 therapeutic regimens 66 docetaxel chemotherapy 66 sorafenib Nexavar ® 66 mRCC 66 pegfilgrastim 66 hepatic metastases 66 bevacizumab Avastin 66 androgen deprivation 66 CHOP chemotherapy 66 chemotherapies 66 FOLFIRI 66 molecularly targeted 66 imatinib Gleevec 66 Panzem R NCD 66 erlotinib Tarceva ® 66 HER2 positive metastatic breast 66 chemotherapeutic drug 66 anti leukemic 66 taxanes 66 Doxil ® 66 gemcitabine 66 CA4P 66 fludarabine 66 platinum refractory 66 azacitidine 65 oxaliplatin 65 Bortezomib 65 tyrosine kinase inhibitors 65 chemotherapy docetaxel 65 epirubicin 65 adriamycin 65 alkylating agents 65 intravenous bisphosphonates 65 nephrotoxicity 65 unresectable 65 5-FU/LV 65 NNRTIs 65 Cytoxan 65 paclitaxel carboplatin 65 biologic therapy 65 taxane therapy 65 uric acid lowering 65 cyclophosphamide 65 warfarin therapy 65 sorafenib Nexavar 65 myeloablative 65 colorectal liver metastases 65 lupus nephritis 65 pegylated interferons 65 Adjuvant chemotherapy 65 ABVD 65 MYLOTARG 65 dasatinib Sprycel 65 immunosuppressive regimens 65 Cisplatin 65 imatinib therapy 65 Trastuzumab 65 chemotherapeutics 65 liposomal doxorubicin 65 Toxicities 65 mapatumumab 65 cardiac toxicity 65 bortezomib 65 anti angiogenic agents 65 non squamous NSCLC 65 paclitaxel Taxol ® 65 APTIVUS r 64 cytoreduction 64 recurrent NSCLC 64 LHRH agonists 64 decitabine 64 interferon therapy 64 postoperative chemotherapy 64 remission induction 64 sunitinib 64 acute GvHD 64 curative resection 64 Fludarabine 64 Herceptin trastuzumab 64 GnRH agonists 64 lipid lowering agents 64 pegylated liposomal doxorubicin 64 hormonal therapies 64 antimetabolite 64 trans retinoic acid 64 metastatic malignant melanoma 64 neoadjuvant 64 cisplatin 64 leucovorin 64 fluorouracil 64 cytarabine 64 fluoropyrimidine 64 chlorambucil 64 chemotherapeutic 64 Xanafide 64 pertuzumab 64 temozolomide 64 concurrent chemoradiation 64 gemcitabine chemotherapy 64 mitoxantrone 64 gemcitabine carboplatin 64 Lenalidomide 64 alkylating agent 64 TKIs 64 palliation 64 PREZISTA r 64 standard chemotherapy regimen 64 recurrent GBM 64 bleomycin 64 immunomodulatory therapy 64 dasatinib Sprycel ® 64 Pemetrexed 64 TNF alpha inhibitors 64 antiangiogenic therapy 64 protease inhibitor PI 64 heavily pretreated 64 stage IIIB 64 relapsed refractory 64 preoperative chemotherapy 64 tanespimycin 64 docetaxel Taxotere 64 DMARDS 64 INTELENCE 64 CsA 64 bendamustine 64 Cloretazine 64 antiplatelet therapy 63 low dose cytarabine 63 systemic corticosteroid 63 trastuzumab Herceptin ® 63 docetaxel Taxotere R 63 DACH platinum 63 Cremophor 63 follicular lymphoma FL 63 fulvestrant 63 thalidomide Thalomid 63 pemetrexed 63 intravenous cyclophosphamide 63 Paraplatin ® 63 EGFR expressing 63 mitomycin C 63 Pegylated Interferon 63 resectable 63 PegIFN RBV 63 surgical debulking 63 virological failure 63 ISTODAX 63 myelosuppression 63 Doxorubicin 63 azathioprine 63 posaconazole 63 interferon alfa 63 adjuvant radiotherapy 63 chemotherapeutic regimen 63 sunitinib malate 63 ribavirin therapy 63 fibrinolytic 63 mTOR inhibitors 63 gefitinib Iressa 63 nucleoside analogues 63 chemoembolization 63 metastatic malignant 63 pancreatic adenocarcinoma 63 EBRT 63 EGFR TKIs 63 oblimersen 63 neoadjuvant therapy 63 hormonal therapy 63 Torisel 63 fibrinolysis 63 intra arterial chemotherapy 63 interferon IFN 63 IFN beta 63 cytotoxic 63 HBeAg negative 63 topotecan 63 ixabepilone 63 Allovectin 7 ® 63 pamidronate 63 imatinib 63 refractory multiple myeloma 63 vincristine 63 refractory AML 63 Platinol ® cisplatin 63 doxorubicin 63 platelet inhibitor 63 gemcitabine Gemzar ® 63 endocrine therapies 63 anti mitotic 63 TORISEL 63 docetaxel 63 allogeneic SCT 63 ribavirin RBV 63 TELCYTA 63 adalimumab 63 lenalidomide Revlimid R 63 IV NSCLC 63 infusional 5-FU/LV 63 trabectedin 63 curative therapy 63 peginterferon 63 gemcitabine cisplatin 63 TNF inhibitor 63 thrombolytic agents 63 Surgical resection 63 nucleoside analogs 63 antiarrhythmic drugs 63 lipid lowering therapies 63 carboplatin 62 galiximab 62 trastuzumab 62 prostate cancer HRPC 62 adjuvant chemotherapy 62 microtubule targeting 62 VAPRISOL 62 tyrosine kinase inhibitor 62 anthracycline containing 62 vandetanib 62 Chemophase 62 Velcade bortezomib 62 receptor tyrosine kinase inhibitor 62 cetuximab 62 SUTENT 62 cytoreductive surgery 62 MGd 62 microwave hyperthermia 62 interferon alfa 2a 62 bone marrow suppression 62 docetaxel Taxotere ® 62 Revlimid lenalidomide 62 goserelin 62 rFVIIa 62 neoadjuvant treatment 62 anticancer therapy 62 Bevacizumab 62 YONDELIS 62 relapsed MM 62 HGS# 62 cranial irradiation 62 Taxotere ® 62 cytoreductive nephrectomy 62 Bezielle 62 proteasome inhibitors 62 fallopian tube carcinoma 62 GP IIb IIIa inhibitors 62 antithrombotics 62 taxane 62 antihypertensive agents 62 dasatinib 62 paclitaxel poliglumex 62 resistant ovarian cancer 62 erlotinib Tarceva 62 ELACYT 62 paclitaxel Taxol 62 HSCT 62 recurrent glioblastoma multiforme 62 boosted protease inhibitor 62 Irinotecan 62 BEACOPP 62 rituximab 62 anticancer therapies 62 dose dexamethasone 62 caspofungin 62 CANCIDAS 62 liposomal amphotericin B 62 Traficet EN 62 Peginterferon alfa 2b 62 irinotecan chemotherapy 62 cystectomy 62 HuLuc# 62 cabazitaxel 62 anthracycline therapy 62 TMP SMX 62 leukemia AML 62 XELOX 62 pharmacokinetic interactions 62 renal dysfunction 62 K ras mutations 62 hypomethylating agents 62 vinca alkaloid 62 radiochemotherapy 62 OPAXIO 62 infusional 62 allogeneic stem cell 62 cardiotoxicity 62 potentially hepatotoxic 62 doxorubicin HCl 62 metastatic bladder 62 direct thrombin inhibitors 62 6 mercaptopurine 62 cisplatin carboplatin 62 elacytarabine 62 invasive candidiasis 62 metastatic GIST 62 panobinostat 62 anthracycline taxane 62 oral clodronate 62 adverse cytogenetics 62 relapsed refractory multiple myeloma 62 EGFR tyrosine kinase inhibitors 62 antiangiogenic agents 62 5 fluorouracil 62 ara C 62 Amrubicin 62 TNF antagonists 62 superficial bladder cancer 62 prostate carcinoma 62 FOLPI 62 clinically localized prostate 62 metastatic kidney 62 inotropic 62 Vidofludimus 62 interferon alfa 2b 62 chemoradiation therapy 61 cetuximab Erbitux ® 61 myelosuppressive 61 LHRH agonist 61 EFAPROXYN 61 lymph node dissection 61 malignant pleural mesothelioma 61 squamous cell histology 61 conventional DMARDs 61 levodopa therapy 61 dosage regimens 61 Peg IFN 61 intravesical 61 IFN alpha 61 alpha interferons 61 LHRH antagonists 61 Radiofrequency ablation 61 TNF antagonist 61 melphalan prednisone 61 pegylated interferon alfa 61 vorinostat 61 TTF Therapy 61 methotrexate therapy 61 lymphadenectomy 61 differentiated thyroid 61 HAART regimen 61 immunosuppressive therapies 61 antithrombotic 61 capecitabine 61 Gemcitabine 61 GISTs 61 immunosuppression 61 relapsed AML 61 5 FU leucovorin 61 5 FU 61 HRPC 61 xanthine oxidase inhibitor 61 histologies 61 trans retinoic acid ATRA 61 FUSILEV enhances 61 myelodysplastic syndrome MDS 61 OncoVEX GM CSF 61 lapatinib Tykerb 61 Navelbine ® 61 Combination therapy 61 EGFR antibodies 61 adecatumumab 61 aromatase inhibitors AIs 61 disease modifying antirheumatic 61 β blockers 61 bortezomib Velcade R 61 MAGE A3 ASCI 61 estramustine 61 proteasome inhibitor bortezomib 61 flutamide 61 Targretin 61 FOLFOX 61 immunosuppressant 61 octreotide 61 pomalidomide 61 temozolomide TMZ 61 gefitinib 61 refractory ovarian cancer 61 iodixanol 61 peginterferon alfa 61 brain metastases 61 ganetespib 61 irbesartan 61 debulking surgery 61 Intravenous CP 61 vascular disrupting agents 61 antianginal 61 chemotherapy regimen 61 Platinol 61 alpha blocker 61 imetelstat 61 adjuvant radiation 61 pimozide 61 eribulin mesylate 61 chemotherapeutic agent 61 Dasatinib 61 bisphosphonate therapy 61 visilizumab 61 PEG interferon 61 DAPT 61 echinocandin 61 FASLODEX 61 thromboembolic events 61 pegylated interferon alfa 2b 61 Gefitinib 61 bicalutamide 61 antithrombotic therapy 61 cilengitide 61 idraparinux 61 adalimumab Humira 61 immunosuppressives 61 typical antipsychotics 61 tocilizumab 61 sorafenib tablets 61 Tamibarotene 61 APTIVUS ritonavir 61 Sorafenib 61 xenograft models 61 BAY #-# 61 Neulasta ® 61 Hycamtin 61 FOLFOX6 61 metastatic HRPC 61 dopaminergic therapy 61 GvHD 61 liver metastasis 61 androgen ablation 61 anti TNFs 60 depsipeptide 60 zoledronic acid 60 mycophenolate 60 chemotherapeutic drugs 60 advanced NSCLC 60 FOLFIRINOX 60 cediranib 60 levodopa carbidopa 60 AGILECT R 60 leukemia CLL 60 acute leukemias 60 pneumonectomy 60 stavudine 60 ibritumomab tiuxetan 60 transplantation HCT 60 neoplasia 60 Fludara ® 60 trastuzumab Herceptin 60 imatinib resistant 60 Mitomycin C 60 nilotinib 60 FluCAM 60 Sanofi Aventis Taxotere 60 imatinib mesylate 60 MYCAMINE 60 irinotecan 60 HGS ETR1 60 amphotericin B 60 IV metastatic melanoma 60 TNF blocker therapy 60 tumor lysis syndrome 60 obatoclax 60 anti TNF 60 hypercalcemia 60 TAXOTERE R 60 PXD# 60 granisetron 60 cetuximab Erbitux R 60 azacytidine 60 dacarbazine DTIC 60 indolent NHL 60 NATRECOR R 60 Vectibix monotherapy 60 unfractionated heparin 60 cytotoxics 60 myeloproliferative diseases 60 Erlotinib 60 TRISENOX 60 antiretroviral regimens 60 systemic corticosteroids 60 refractory prostate cancer 60 PREZISTA rtv 60 sapacitabine 60 pheochromocytoma 60 toxicities 60 MDS AML 60 virologic failure 60 antifungal therapy 60 TNF inhibitors 60 palifermin 60 Rituximab 60 triphendiol 60 PegIFN 60 nephrotoxic 60 d4T stavudine Zerit 60 relapsed multiple myeloma 60 angiotensin converting enzyme inhibitors 60 CYT# potent vascular disrupting 60 alpha 2a 60 metastatic CRC 60 imatinib Gleevec ® 60 Docetaxel 60 cytopenias 60 refractory PTCL 60 nucleoside reverse transcriptase inhibitor 60 androgen suppression 60 GnRH agonist 60 skeletal metastases 60 PDE4 inhibitors 60 interferon beta therapy 60 endothelin receptor antagonists 60 sorafenib 60 Taxotere R 60 prostate cancer CRPC 60 CMV disease 60 transurethral resection 60 palifosfamide 60 paricalcitol 60 nucleoside analog 60 recurrent ovarian cancer 60 TELINTRA 60 elotuzumab 60 locoregional recurrence 60 cardiotoxic 60 Gliadel Wafer 60 thrombolytics 60 NNRTI 60 radical cystectomy 60 severe renal impairment 60 neutropenic patients 60 Hodgkin lymphoma NHL 60 tamoxifen therapy 60 interferon ribavirin 60 NRTI 60 Capecitabine 60 pharmacologically active isomer 60 cytarabine daunorubicin 60 medically inoperable 60 ritonavir boosted protease inhibitor 60 MMP inhibitors 60 nab paclitaxel 60 Mylotarg 60 anticoagulant therapy 60 amrubicin 60 calcineurin inhibitor 60 anthracyclines taxanes 60 prostate cancer CaP 60 JAK2 inhibitors 60 antihypertensive therapy 60 anticancer treatments 60 TEMODAL 60 mg/m2 dose 60 rituximab Rituxan 60 Camptosar 60 Zevalin consolidation 60 Calcineurin inhibitors 60 severe neutropenia 60 concomitant medications 60 haematological malignancies 60 IMC A# 60 IIIa inhibitor 60 sargramostim 60 GnRH antagonist 60 intradermal injection 60 cervical carcinoma 60 vinca alkaloids 60 radiotherapy RT 60 non metastatic osteosarcoma 60 liver metastases 60 Akt activation 60 intraperitoneal chemotherapy 60 metastatic colon cancer 60 CBLC# 60 pCR 60 nephrectomy 60 FOLFOX4 60 CIMZIA TM 60 antiandrogen 60 ritonavir boosted lopinavir 60 antidiabetic drugs 60 antidiabetic 60 aspirin clopidogrel 60 nilotinib Tasigna ® 60 MEK inhibitors 60 cyclophosphamide Cytoxan 60 SERMs 60 dose escalation 60 myopathy rhabdomyolysis 60 forodesine 60 unresectable stage 60 Imatinib 60 abiraterone acetate 60 colorectal cancer liver metastases 60 tamoxifen Nolvadex ® 60 follicular NHL 60 cranial radiation 60 aprepitant 60 bexarotene 60 gastrointestinal stromal tumors GIST 60 advanced hepatocellular carcinoma 60 oral anticoagulation 60 cell lymphoma CTCL 60 Corticosteroids 60 pyridostigmine 60 stavudine d4T 60 MAO inhibitors 59 VIDAZA 59 Alocrest 59 hepatocellular carcinoma HCC 59 haematologic 59 FIRMAGON 59 refractory Hodgkin lymphoma 59 Symadex 59 seliciclib 59 B CLL 59 INCB# [001] 59 pelvic lymphadenectomy 59 bortezomib Velcade 59 TroVax ® 59 Camptosar ® 59 erythropoietic 59 VELCADE melphalan 59 systemic antifungal 59 chemoresistance 59 doxorubicin Adriamycin 59 Taxol ® 59 Oral corticosteroids 59 antiangiogenic 59 epithelial tumors 59 Voreloxin 59 myelodysplastic syndromes 59 refractory NSCLC 59 mitochondrial toxicity 59 antiemetics 59 Doxil 59 nucleoside 59 NSAID therapy 59 dexrazoxane 59 cisplatin gemcitabine 59 LHRH 59 TNF alpha inhibitor 59 somatostatin analogue 59 infliximab 59 sulphonylurea 59 immunosuppressant therapy 59 antiandrogens 59 AQ4N 59 Platinol ® 59 HQK 59 antiviral therapy 59 G CSF 59 ALT flares 59 farletuzumab 59 immunosuppressive medications 59 Gleevec resistant 59 SCCHN 59 micafungin 59 anthracycline chemotherapy 59 angiotensin converting enzyme inhibitor 59 oral NSAIDs 59 relapsing MS 59 Telintra 59 EndoTAGTM 1 59 T#I mutation 59 peg interferon 59 Cloretazine R VNP#M 59 axitinib 59 mCRC patients 59 monotherapy 59 castrate resistant 59 Carboplatin 59 renal toxicity 59 hematologic disorders 59 FOLFOX regimen 59 conventional antipsychotics 59 rHuPH# 59 TYKERB 59 Gleevec imatinib 59 HAART regimens 59 Bleomycin 59 oral anticoagulants 59 plus gemcitabine 59 APTIVUS 59 JAK inhibitors 59 zalutumumab 59 mercaptopurine 59 sulfasalazine 59 Tyrima 59 radical nephrectomy 59 chemosensitivity 59 gastrointestinal stromal tumor GIST 59 dose corticosteroids 59 oral Hycamtin 59 thalidomide dexamethasone 59 saline placebo 59 Cetuximab 59 ovarian carcinoma 59 HDACi 59 ritonavir boosted 59 romidepsin 59 melphalan 59 Hepatocellular Carcinoma HCC 59 quinolone 59 solar keratoses 59 Tarceva erlotinib 59 chemotherapy cisplatin 59 H. pylori eradication 59 adjuvant therapies 59 methotrexate 59 mycophenolate mofetil MMF 59 noninfectious uveitis 59 Perifosine 59 grade cervical intraepithelial 59 radiolabeled monoclonal antibody 59 Elacytarabine 59 alvespimycin 59 Ceplene/IL-2 59 HER2 overexpression 59 tigecycline 59 proteasome inhibitor 59 alfa 2a 59 L asparaginase 59 VNP#M 59 systemic ALCL 59 5-fluorouracil/leucovorin 59 eplerenone 59 Interferon alpha 59 Aplidin 59 tipranavir 59 insulin detemir 59 castration resistant prostate cancer 59 ß blockers 59 Elitek 59 doxorubicin cyclophosphamide 59 immunosuppressive regimen 59 Nilotinib 59 taxotere 59 virologic response 59 immunomodulation 59 romiplostim 59 ASCT 59 recurrent glioblastoma 59 Gemzar ® 59 luteinizing hormone releasing 59 capecitabine Xeloda 59 sulfonylurea 59 glioblastoma multiforme GBM 59 phosphate binders 59 mycosis fungoides 59 arsenic trioxide 59 serous ovarian cancer 59 refractory acute myeloid 59 adjuvant tamoxifen 59 nephrotoxic drugs 59 CoFactor 59 metastatic relapsed 59 chemotherapy induced neutropenia 59 fluvastatin 59 aflibercept 59 cytostatic 59 immunomodulators 59 veltuzumab 59 CIMZIA ™ 59 glufosfamide 59 olaparib 59 erlotinib 59 amoxicillin clavulanate 59 antiepileptics 59 LMWH 59 CTAP# Capsules 59 sunitinib Sutent 59 metastatic hormone refractory 59 NMIBC 59 VEGF inhibitors 59 corticosteroid dexamethasone 59 durable remissions 59 bevacizumab 59 bone metastasis 59 anti resorptive 59 Oxaliplatin 59 thromboprophylaxis 59 grade gliomas 59 Allovectin 7 59 pancreatic NET 59 dacetuzumab 59 iniparib 59 prednisone prednisolone 59 lamivudine 59 Decitabine 59 hydroxychloroquine 59 pegylated interferon alfa 2a 59 olmesartan 59 hematologic malignancies 59 radioiodine therapy 59 cidofovir 59 fondaparinux 59 BEXXAR 59 EOquin 59 ELOXATIN 59 relapsing multiple sclerosis 59 Fulvestrant 59 pazopanib 59 transarterial chemoembolization 59 chemo radiotherapy 59 tiuxetan 59 5 fluorouracil leucovorin 59 intravesical therapy 59 viral kinetics 59 LOVENOX R 59 lenalidomide 59 renoprotective 59 alteplase 59 efavirenz EFV 59 factor Xa inhibitor 59 palliative radiotherapy 59 potassium sparing diuretics 59 antiangiogenic agent 59 antiretroviral regimen 59 infliximab Remicade 59 relapsed CLL 59 nonmyeloablative 59 ICD implantation 59 tumor necrosis 59 LEP ETU 59 antiepileptic drugs AEDs 59 Levodopa 59 antitumor activity 58 tyrosine kinase inhibitor TKI 58 bevacizumab Avastin Genentech 58 nonmelanoma skin cancers 58 enzastaurin 58 distant metastases 58 intraperitoneal therapy 58 Neoadjuvant 58 NSCLC 58 placebo dexamethasone 58 urothelial bladder cancer 58 DFMO 58 Amigal 58 EGFR TKI 58 Neuradiab 58 Imprime PGG 58 AEG# 58 rhGH 58 IV bisphosphonates 58 imatinib resistance 58 dosing frequency 58 raltegravir 58 paclitaxel chemotherapy 58 tumor recurrence 58 Taxotere chemotherapy 58 biologic DMARD 58 Peginterferon 58 Paraplatin ® carboplatin 58 XmAb# 58 carbidopa levodopa 58 paroxysmal AF 58 ganciclovir 58 pyrazinamide 58 receiving VICTRELIS 58 ifosfamide 58 immunoconjugate 58 bladder carcinoma 58 chemotherapy radiotherapy 58 treatment regimens 58 anticancer agents 58 androgen suppression therapy 58 SCIg 58 irinotecan doxorubicin oxaliplatin paclitaxel 58 adjuvant trastuzumab 58 paclitaxel Taxol R 58 figitumumab 58 Caelyx 58 Gleevec imatinib mesylate 58 HuMax CD4 58 3TC lamivudine Epivir 58 Taxol paclitaxel 58 metformin sulfonylurea 58 panitumumab Vectibix 58 dexamethasone Decadron 58 sleeve lobectomy 58 vWD 58 methotrexate MTX 58 antimicrobial prophylaxis 58 sorafenib Nexavar R 58 anti VEGF 58 riociguat 58 LHRH analogues 58 Cytarabine 58 mTOR inhibitor 58 taxane refractory 58 relapsed acute myelogenous 58 situ CIS 58 Gemzar gemcitabine 58 BCG refractory 58 salmeterol fluticasone 58 Vicinium TM 58 autologous transplants 58 myelofibrosis polycythemia vera 58 transaminase elevation 58 MGCD# [001] 58 monotherapies 58 genotypic resistance 58 Vidaza azacitidine 58 revascularization procedures 58 titrated glipizide 58 carbidopa 58 metastatic castration resistant 58 ritonavir boosting 58 plasminogen activators 58 microtubule inhibitor 58 low dose dexamethasone 58 chronic lymphocytic leukemia CLL 58 letrozole Femara 58 cinacalcet 58 TNFa 58 androgen independent 58 nucleoside analogue 58 combinability 58 epoprostenol 58 operable breast cancer 58 sentinel lymph node biopsy 58 glatiramer acetate Copaxone 58 renal tumors 58 myelodysplastic syndromes MDS 58 mg kg dose 58 doxorubicin HCl liposome injection 58 CYP #A# 58 chemotherapy 58 gemifloxacin 58 hepatocellular carcinoma 58 immunomodulatory 58 galantamine 58 octreotide LAR 58 HCV protease inhibitors 58 radiation sensitizer 58 pegylated interferon 58 VDAs 58 refractory chronic lymphocytic 58 antiemetic 58 interferon 58 chronic GVHD 58 systemic toxicity 58 efalizumab 58 pimecrolimus 58 antihypertensive medication 58 antitumor effect 58 renal insufficiency 58 Hycamtin ® 58 IFN α 58 Pertuzumab 58 gadobutrol 58 refractory CLL